Crinetics Pharmaceuticals (CRNX) Revenue (2017 - 2026)

Crinetics Pharmaceuticals' Revenue history runs 10 years deep, the most recent figure standing at $10.7 million for Q1 2026.

• In Q1 2026, Revenue rose 2873.41% year-over-year to $10.7 million; the TTM figure through Mar 2026 stood at $18.1 million (up 2277.5% YoY), while the FY2025 annual figure was $7.7 million, up 640.71% from the prior year.
• Revenue was $10.7 million for Q1 2026 at Crinetics Pharmaceuticals, up from $6.2 million in the prior quarter.
• In the past five years, Revenue ranged from a high of $10.7 million in Q1 2026 to a low of $143000.0 in Q3 2025.
• Historically, Revenue has averaged $2.0 million across 5 years, with a median of $674500.0 in 2022.
• The sharpest annual moves came in 2024 and 2026: Revenue slumped 76.11% in 2024, then jumped 2873.41% in 2026.
• A 5-year view of Revenue shows it stood at $709000.0 in 2022, then sank by 51.2% to $346000.0 in 2023, then grew by 15.32% to $399000.0 in 2024, then soared by 1444.11% to $6.2 million in 2025, then jumped by 74.22% to $10.7 million in 2026.
• The last three Revenue figures came in at $10.7 million (Q1 2026), $6.2 million (Q4 2025), and $143000.0 (Q3 2025), per Business Quant data.